Creative Diagnostics Introduces New H5N1 Antibodies and Antigens for Research Applications

Creative Diagnostics announces the launch of its new line of H5N1 Antibodies and Antigens.
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, is excited to announce the launch of its new line of H5N1 Antibodies and Antigens [https://www.creative-diagnostics.com/h5n1-antibodies-and-antigens.htm] to support cutting-edge research on this highly pathogenic influenza A virus subtype. These innovative products offer researchers and scientists invaluable tools for studying and combating the H5N1 influenza virus.

Influenza A virus is a genus of virus in the family Orthomyxoviridae and causes influenza in birds and some mammals. Influenza A virus strains of all subtypes have been isolated from wild birds, but disease is rare. Some isolated influenza A viruses cause severe disease in poultry and, in rare cases, in humans. Sometimes the virus is transmitted from wild waterfowl to poultry, which can lead to outbreaks or cause human influenza pandemics.

H5N1 is a subtype of influenza A virus and belongs to the genus Alpha influenza virus in the family Orthomyxoviridae. The genome of this RNA virus is segmented and consists of eight negative-sense single-stranded RNAs, abbreviated as PB2, PB1, PA, HA, NP, NA, MP, and NS. The major glycoproteins on the surface of the virus are hemagglutinin (H) and neuraminidase (N). H5N1 refers to the fact that the virus has a type 5 hemagglutinin protein and a type 1 neuraminidase protein. These proteins are antigenic when the virus infects host cells and are the primary targets of antibodies and antiviral drugs.

Highly pathogenic avian influenza H5N1 viruses were first detected in domesticated waterfowl in southern China in 1996. Since 2020-2021, H5N1 2.3.4.4b clade viruses have become widespread in wild birds worldwide, leading to outbreaks in poultry and other animals. In the spring of 2024, H5N1 2.3.4.4b clade viruses have also been detected in milk samples from cows and in raw milk in several states in the United States, causing significant global concern due to their serious impact on poultry and wildlife populations and potential risk to human health.

Influenza A viruses contain multiple subtypes and strains that frequently undergo genetic drift and transformation, posing a threat to human and animal health and life worldwide. Creative Diagnostics offers a wide range of high-quality antibody and antigen products related to the H5N1 influenza virus that are validated for use in a variety of assays, including Inactivated IAV H5N1 Native Antigens, Recombinant IAV H5N1 Antigens, and IAV H5N1 Antibodies.

Creative Diagnostics is committed to providing researchers with the tools they need to drive scientific discovery. By offering a comprehensive portfolio of H5N1 Antibodies and Antigens, the company is supporting the global effort to develop effective strategies for preventing and treating H5N1 infections.

To learn more about these antibodies and other research tools, please visit https://www.creative-diagnostics.com/h5n1-antibodies-and-antigens.htm.

About Creative Diagnostics

Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components, and critical assay reagents. In addition to providing contract R&D and biologic manufacturing services for diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market, the company aims to continue to act as a trusted source for all researchers' assay development and manufacturing needs.

Media Contact
Company Name: Creative Diagnostics
Contact Person: Thomas Schmitt
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=creative-diagnostics-introduces-new-h5n1-antibodies-and-antigens-for-research-applications]
State: New York
Country: United States
Website: https://www.creative-diagnostics.com/



This release was published on openPR.